ALK-Abelló A/S
ALK-B
株式のランク
#2351
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
株価
$37.79
時価総額
$8.38B
変化（1日）
4.29%
変化（1年）
15.32%
国
DK
取引 ALK-Abelló A/S (ALK-B)
カテゴリー
Healthcare
ALK-Abelló A/S（ALK-B）の営業利益率
October 2026 時点の営業利益率 TTM: 26.71%
ALK-Abelló A/S の最新の財務報告と株価によると、現在の営業利益率（TTM）は 26.71% です。2023 年末時点では 13.81% でした。
ALK-Abelló A/S の営業利益率の履歴（2004 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 26.71% | 35.58% |
| 2024 | 19.70% | 42.65% |
| 2023 | 13.81% | 32.53% |
| 2022 | 10.42% | 39.68% |
| 2021 | 7.46% | 73.49% |
| 2020 | 4.30% | -1,100.00% |
| 2019 | -0.43% | -86.93% |
| 2018 | -3.29% | 19.64% |
| 2017 | -2.75% | -117.25% |
| 2016 | 15.94% | 40.19% |
| 2015 | 11.37% | 4.79% |
| 2014 | 10.85% | 123.25% |
| 2013 | 4.86% | -3.38% |
| 2012 | 5.03% | -60.49% |
| 2011 | 12.73% | 43.19% |
| 2010 | 8.89% | -1.66% |
| 2009 | 9.04% | 35.53% |
| 2008 | 6.67% | -49.47% |
| 2007 | 13.20% | 270.79% |
| 2006 | 3.56% | 2,125.00% |
| 2005 | 0.16% | -97.72% |
| 2004 | 7.02% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 38.59% | -98.56% |
US
|
|
| -149.01% | -105.58% |
US
|
|
| 25.57% | -99.04% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -98.92% |
NL
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。